HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Q2 Lifted By Consumer Biz Revival And ‘Probably Our Greatest Makeup Launch Ever’

Executive Summary

Maybelline Lash Sensational Sky High Mascara, along with NYX Shine Loud Lip Color and L’Oreal Paris Infallible Fresh Wear 24HR Foundation, were among innovations gobbled up by makeup-hungry consumers in the second quarter, which helped fuel 23% growth in North America in L'Oreal's fiscal 2021 first half.

You may also be interested in...



US Makeup Sales Remain Down Versus Pre-Pandamic; ‘Above-The-Mask’ Products Continue To Lead

Overall US makeup sales in the US were still lower in 2021 (to 4 December) compared with pre-pandemic figures, but a number of sub-categories showed marked improvement late in the year, according to a Jefferies Equity Research report. Notably, eye makeup sales rose 1.9% in the final weeks of the analyzed period.

Global Beauty And Personal Care Growth Unleashed Despite Market Tensions In Changed World

The Global Wellness Institute outlines trends shaping the post-pandemic beauty and personal-care space, projected to see annual growth in excess of 8% from 2020 through 2025.

L’Oreal Third-Quarter Sales In US Stores Surge Without Slowing E-commerce Results

With US sales in stores up nearly 27% for 2021 through the third quarter, e-commerce sales “have not been slowed down,” says CEO Nicolas Hieronimus. Both channels strong as market conditions cater to in-store and online shoppers, he suggests.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel